umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Novel agents in the treatment of non-small cell lung cancer: implications for neoadjuvant chemotherapy?
Umeå University, Faculty of Medicine, Radiation Sciences, Oncology.
2005 (English)In: In Vivo, ISSN 0258-851X, Vol. 19, no 3, 523-533 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2005. Vol. 19, no 3, 523-533 p.
Keyword [en]
Lung cancer, neoadjuvant chemotherapy, NSCLC, pemetrexed, EGFR-inhibiting agents, anti-angiogenesis inhibitors, cisplatin, gemcitabine, review
Identifiers
URN: urn:nbn:se:umu:diva-14281PubMedID: 15875771OAI: oai:DiVA.org:umu-14281DiVA: diva2:153952
Available from: 2007-02-23 Created: 2007-02-23 Last updated: 2011-01-12Bibliographically approved

Open Access in DiVA

No full text

PubMed

Search in DiVA

By author/editor
Henriksson, Roger
By organisation
Oncology

Search outside of DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric score

pubmed
urn-nbn
Total: 26 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf